Total Payments
$5,356
2024 Payments
$70.09
Companies
34
Transactions
318
Medicare Patients
13,054
Medicare Billing
$931,960
Payment Breakdown by Category
Food & Beverage$5,234 (97.7%)
Education$121.69 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,234 | 316 | 97.7% |
| Education | $121.69 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,063 | 70 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $533.30 | 31 | $0 (2023) |
| Amgen Inc. | $516.16 | 32 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $467.62 | 26 | $0 (2023) |
| PFIZER INC. | $388.02 | 24 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $303.60 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $271.87 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $224.76 | 15 | $0 (2023) |
| Boston Scientific Corporation | $206.79 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $206.79 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70.09 | 2 | Boston Scientific Corporation ($70.09) |
| 2023 | $783.71 | 38 | Actelion Pharmaceuticals US, Inc. ($161.82) |
| 2022 | $620.22 | 39 | Novartis Pharmaceuticals Corporation ($186.21) |
| 2021 | $557.58 | 38 | Novartis Pharmaceuticals Corporation ($133.61) |
| 2020 | $300.39 | 18 | Janssen Pharmaceuticals, Inc ($59.50) |
| 2019 | $920.25 | 57 | Novartis Pharmaceuticals Corporation ($189.66) |
| 2018 | $993.48 | 58 | Novartis Pharmaceuticals Corporation ($223.72) |
| 2017 | $1,110 | 68 | Novartis Pharmaceuticals Corporation ($256.72) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 03/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $37.88 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/17/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardiology | ||||||
| 10/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.46 | General |
| 10/06/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.91 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/22/2023 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $36.25 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/07/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Genetic Disease | ||||||
| 09/05/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Cardiology | ||||||
| 08/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.98 | General |
| 08/18/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/16/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/16/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiology | ||||||
| 08/15/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $99.99 | General |
| Category: Cardiology | ||||||
| 08/10/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: Cardiovascular | ||||||
| 08/08/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Cardiology | ||||||
| 07/26/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Medical Device | ||||||
| 07/13/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/07/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/06/2023 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: WATCHMAN Pro_IC | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,439 | 6,260 | $870,846 | $265,547 |
| 2022 | 26 | 3,200 | 4,793 | $764,134 | $234,283 |
| 2021 | 24 | 3,223 | 4,374 | $694,346 | $211,055 |
| 2020 | 23 | 3,192 | 4,616 | $718,551 | $221,076 |
Total Patients
13,054
Total Services
20,043
Medicare Billing
$931,960
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 426 | 688 | $144,480 | $60,785 | 42.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 177 | 1,203 | $102,255 | $55,928 | 54.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 139 | 842 | $109,460 | $32,085 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 149 | 155 | $55,800 | $19,570 | 35.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 111 | 112 | $95,200 | $16,746 | 17.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 112 | 304 | $33,440 | $11,738 | 35.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 205 | 206 | $37,080 | $10,802 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 65 | $18,525 | $8,085 | 43.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 912 | 1,287 | $145,767 | $7,888 | 5.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 91 | 178 | $14,240 | $6,462 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $16,470 | $6,254 | 38.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 459 | 556 | $36,140 | $6,070 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 100 | $15,000 | $5,703 | 38.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 88 | 106 | $7,950 | $3,901 | 49.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 63 | $7,875 | $3,836 | 48.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 33 | $5,874 | $2,835 | 48.3% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 96 | 97 | $7,760 | $2,793 | 36.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 87 | 87 | $3,480 | $1,297 | 37.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 27 | 38 | $3,420 | $1,165 | 34.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 21 | 21 | $6,300 | $1,099 | 17.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 18 | 18 | $1,890 | $354.78 | 18.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 17 | 17 | $2,210 | $95.88 | 4.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 23 | 23 | $230.00 | $56.12 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 386 | 633 | $132,930 | $58,150 | 43.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 94 | 633 | $53,805 | $29,557 | 54.9% |
About Dr. Michael Bunda, M.D
Dr. Michael Bunda, M.D is a Cardiovascular Disease healthcare provider based in Prince George, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912955451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bunda, M.D has received a total of $5,356 in payments from pharmaceutical and medical device companies, with $70.09 received in 2024. These payments were reported across 318 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,234).
As a Medicare-enrolled provider, Bunda has provided services to 13,054 Medicare beneficiaries, totaling 20,043 services with total Medicare billing of $931,960. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Prince George, VA
- Active Since 05/05/2006
- Last Updated 10/30/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912955451
Products in Payments
- ENTRESTO (Drug) $1,014
- XARELTO (Drug) $533.30
- ELIQUIS (Drug) $446.56
- MULTAQ (Drug) $413.83
- Corlanor (Drug) $262.80
- BRILINTA (Drug) $258.82
- Repatha (Biological) $253.36
- VERQUVO (Drug) $224.76
- LifeVest (Device) $206.79
- OPSUMIT (Drug) $138.04
- PRADAXA (Drug) $102.91
- PRALUENT ALIROCUMAB INJECTION (Biological) $86.83
- WATCHMAN FLX (Device) $70.09
- LEXISCAN (Drug) $61.31
- Savaysa (Drug) $54.74
- NEXLETOL (Drug) $54.56
- PRALUENT (Drug) $53.79
- Vascepa (Drug) $50.53
- LEQVIO (Drug) $49.38
- WATCHMAN Access System (Device) $45.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.